These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 5529995

  • 1. [Diacetyl-glucaro-(1 leads to 4) (6 leads to 3)-dilactone (SLA) for prevention of bladder tumor recurrence].
    Shiraishi T, Nihira H.
    Hinyokika Kiyo; 1970 Oct; 16(10):586-92. PubMed ID: 5529995
    [No Abstract] [Full Text] [Related]

  • 2. [Preventive effect of beta-glucuronidase inhibitor (SLA) on recurrence of the bladder tumor].
    Miyagawa M, Harada T, Yoshida O, Kato T.
    Hinyokika Kiyo; 1970 Dec; 16(12):738-44. PubMed ID: 5531642
    [No Abstract] [Full Text] [Related]

  • 3. [A study of prophylaxis for recurrence of bladder tumor. Some statistical and experimental studies on the long term administration of -glucuronidase inhibitor (2,5-di-o-acetyl, D-glucaro(1-4)(6-3) dilactone) to patients of bladder tumor].
    Katayama Y.
    Nihon Hinyokika Gakkai Zasshi; 1972 Nov; 63(11):951-71. PubMed ID: 4675186
    [No Abstract] [Full Text] [Related]

  • 4. The effect of urinary -glucuronidase inhibition on the induction of bladder tumors with 2-acetylaminofluorene in rats.
    Miyakawa M, Yoshida O, Harada T, Kato T.
    Invest Urol; 1973 Jan; 10(4):256-61. PubMed ID: 4683376
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical study on prophylaxis of diacetyl-glucaro-(1-4) (6-3) dilactone for recurrence of bladder cancer].
    Isomatsu Y, Kaburagi Y, Jinbo S, Nashimo T, Miki M, Yamanaka H.
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1958-62. PubMed ID: 6614934
    [Abstract] [Full Text] [Related]

  • 6. [Clinical application of glucarolactone to bladder tumor. II. Effect of SLA on recurrence of bladder tumor].
    Yonese Y.
    Nihon Hinyokika Gakkai Zasshi; 1970 Oct; 61(10):995-1003. PubMed ID: 5529307
    [No Abstract] [Full Text] [Related]

  • 7. Clinical application of 2,5-DI-O-acetyl- -D-gluca ro- (1-4) (6-3)-dilactone (SLA) to the bladder tumor, with special reference to its effect on frequency of tumor recurrences.
    Ichikawa T.
    J Urol; 1972 Oct; 108(4):571-6. PubMed ID: 4654258
    [No Abstract] [Full Text] [Related]

  • 8. [Problems of recurrence of bladder tumor].
    Niijima T.
    Nihon Ishikai Zasshi; 1971 Sep; 66(5):497-502. PubMed ID: 5165600
    [No Abstract] [Full Text] [Related]

  • 9. [Study of preventive effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU) or combination of HCFU and 2.5-di-O-acetyl-D-glucaro (1-4) (6-3) dilactone (SLA) after preservative operation against bladder cancer].
    Wada S, Yasumoto R, Kashihara N, Kishimoto T, Maekawa M, Hayahara N, Kawakita J, Nishijima T, Morikawa Y, Horii A.
    Hinyokika Kiyo; 1992 Jan; 38(1):19-24. PubMed ID: 1546564
    [Abstract] [Full Text] [Related]

  • 10. [Effects of 2,5-di-O-acetyl-D-glucaro-(1,4) (6,3)-dilactone (SLA) on experimental bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Ito N, Hiasa Y, Kamamoto Y, Makiura S, Okajima E.
    Gan No Rinsho; 1970 Sep; 16(10):995-1001. PubMed ID: 5528978
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on urinary beta-glucuronidase in patients with bladder cancer].
    Tamiya T.
    Sapporo Igaku Zasshi; 1966 Sep; 29(5):269-303. PubMed ID: 5338305
    [No Abstract] [Full Text] [Related]

  • 12. [Tumor recurrence prevention using photodynamic therapy after treatment of bladder cancer].
    Sun X, Li H, Wang M.
    Zhonghua Wai Ke Za Zhi; 1995 Mar; 33(3):179-80. PubMed ID: 7555391
    [Abstract] [Full Text] [Related]

  • 13. [The effect of added dietary beta-glucuronidase inhibitor on the occurrence of 2-acetyl-aminofluorene induced bladder tumors in rats].
    Miyakawa M.
    Hinyokika Kiyo; 1970 Nov; 16(11):653-69. PubMed ID: 5530618
    [No Abstract] [Full Text] [Related]

  • 14. [A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection].
    Sakai Y, Fujii Y, Hyochi N, Masuda H, Kawakami S, Kobayashi T, Kageyama Y, Kihara K.
    Hinyokika Kiyo; 2006 Mar; 52(3):173-5. PubMed ID: 16617868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
    Oosterlinck W.
    Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of the recurrence of superficial bladder cancer].
    Flamm J, Grof F.
    Z Urol Nephrol; 1984 Mar; 77(3):129-36. PubMed ID: 6720112
    [Abstract] [Full Text] [Related]

  • 20. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
    Matveev BP, Kariakin OB, Safiullin KN, Figurin KM, Levi DT, Vatin OE.
    Urol Nefrol (Mosk); 1993 Mar; (5):27-9. PubMed ID: 8310581
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.